Meeting
2023 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
Authors
Minas P. Economides
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY
Minas P. Economides , Jonathan Lee , Xiaochun Li , Mari Nakazawa , Lucas Hollifield , Michal Sarfaty , Judith D. Goldberg , Emmanuel S. Antonarakis , David R Wise
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT02621151
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 139)
DOI
10.1200/JCO.2023.41.6_suppl.139
Abstract #
139
Poster Bd #
D20
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Germline APC (I1307K) mutation and clinical outcomes in prostate cancer.
First Author: Minas P. Economides
Poster
2018 ASCO Annual Meeting
Clinical outcomes with cumulative tumor suppressor gene (TSG) alterations in castration sensitive (CSPC) and resistant (CRPC) prostate cancer.
First Author: Anis Hamid
Poster
2024 ASCO Genitourinary Cancers Symposium
Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy.
First Author: Aishwarya Subramanian
Poster
2024 ASCO Genitourinary Cancers Symposium
Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.
First Author: Asli Munzur